Skip to main content

Webcasts & Webinars

Panel discussion: Recent advances in early and advanced stage non-small cell lung cancer (NSCLC) presented at ESMO 2023

NSCLC Panel Discussion

Dr. Luis Paz-Ares, Prof. Solange Peters and Dr. Marina Garassino provide their insights on the latest findings from the following pivotal phase III trials: ALINA, CheckMate-77T, LIBRETTO-431, and MARIPOSA-1 and -2.

Supported by:
  • F. Hoffmann-La Roche Ltd.

ESMO23: Small-cell lung cancer highlights

SCLC Expert Interview

Dr. Luis Paz-Ares and Andrea Ardizzoni discuss the top small-cell lung cancer abstracts presented at ESMO 2023.

Supported by:
  • F. Hoffmann-La Roche Ltd.

Cancer of Unknown Primary: Key results from ESMO 2023

ESMO 2023 gave researchers the opportunity to highlight advances in the molecular diagnosis and treatment for cancer of unknown primary.

Watch our video interviews to find out more about the latest developments for patients with this rare diagnosis.

Supported by:
  • F. Hoffmann-La Roche Ltd.

ESMO 2023: A new option for thyroid cancer

Thyroid Cancer Expert Interview

Dr. Laura Locati comments on the LIBRETTO-531 study of selpercatinib in previously untreated RET-mutant medullary thyroid carcinoma, which has provided a new treatment option for this patient population.

ESMO 2023: Advances in urothelial cancer

Urothelial Cancer Expert Interview

Dr. Enrique Grande discusses the findings of the EV-302 trial of enfortumab vedotin plus pembrolizumab and the CheckMate 901 trial of nivolumab plus chemotherapy, both conducted in the advanced urothelial cancer setting.

ESMO 2023: Hot topics in gynecologic cancer

Gynecologic Cancer Expert Interview

Dr. Domenica Lorusso takes us through the key gynecologic cancer studies presented at the conference, including the KEYNOTE-A18 and innovaTV 301 trials in cervical cancer and DUO-E in endometrial cancer.

Expert commentary on the management of cardiomyopathies

Cardiomyopathy Expert Interview

Professor Johann Bauersachs discusses the new ESC guidelines on cardiomyopathy, which for the first time cover the broad range of cardiomyopathies. He highlights some red flags for diagnosis, and the importance of patient involvement in disease management. 

Expert commenary on iron supplementation therapy and heart failure

Heart Failure Expert Interview

Professor Michael Böhm explains the importance of treating iron deficiency in heart failure patients, considering the results of the HEART-FID trial and pooled individual patient data from three RCTs.

Expert commentary on the management of cardiovascular disease in patients with diabetes

Professor Nikolaus Marx discusses the new ESC guidelines on screening and stratification of patients with diabetes, and the importance of person-centred therapeutic strategies to reduce patients' cardiovascular risk.

New guidelines for the management of cardiomyopathies

Watch the official ESC video recording of the presentation of the first international guideline covering all subtypes of cardiomyopathies, except HCM.

Guidelines for the management of cardiovascular disease in patients with diabetes

Watch the official ESC video recording of the presentation of the international guideline for prevention and management of CVD in patients with diabetes.

Guidelines for the management of endocarditis

Watch the official ESC video recording of the presentation of updated international guidelines for the diagnosis and management of patients with infective endocarditis.